Azacitidine for Treatment of Therapy Related Myelodysplastic Syndrome

被引：0
|
作者：
Komrokji, Rami S. [1 ]
Al Ali, Najla H. [1 ]
Alrawi, E. [1 ]
Padron, Eric [1 ]
Perkins, Janelle [2 ]
Field, Teresa [1 ]
Lancet, Jeffrey E. [1 ]
List, Alan F. [2 ]
机构：
[1] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：745 / 746
页数：2
相关论文
共 50 条
  • [1] Azacitidine for the treatment of myelodysplastic syndrome
    Cataldo, Vince D.
    Cortes, Jorge
    Quintas-Cardama, Alfonso
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (07) : 875 - 884
  • [2] Treatment of Myelodysplastic syndrome with azacitidine and erythropoietin
    Limaye, Sewanti
    Lipshitz, Jay
    Dulala, Renuka
    Patel, Dilip
    BLOOD, 2007, 110 (11) : 230B - 230B
  • [3] Clonal Selection in Therapy Related Myelodysplastic Syndromes Under Azacitidine Treatment
    Calleja, Anne
    Moreilhon, Chimene
    Karsenti, Jean Michel
    Gastaud, Lauris
    Mannone, Lionel
    Dadone, Berengere
    Robert, Guillaume
    Auberger, Patrick
    Raynaud, Sophie
    Cluzeau, Thomas
    BLOOD, 2017, 130
  • [4] Treatment outcome of 5′-azacitidine for myelodysplastic syndrome
    Kim, Y. K.
    Kim, H. J.
    Song, J. E.
    Kim, S. E.
    Ahn, J. S.
    Yang, D. H.
    Lee, J. J.
    LEUKEMIA RESEARCH, 2013, 37 : S110 - S110
  • [5] Successful azacitidine therapy for myelodysplastic syndrome associated with VEXAS syndrome
    Kataoka, Asami
    Mizumoto, Chisaki
    Kanda, Junya
    Iwasaki, Makoto
    Sakurada, Maki
    Oka, Tomomi
    Fujimoto, Masakazu
    Yamamoto, Yosuke
    Yamashita, Kohei
    Nannya, Yasuhito
    Ogawa, Seishi
    Takaori-Kondo, Akifumi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2023, 117 (06) : 919 - 924
  • [6] Successful azacitidine therapy for myelodysplastic syndrome associated with VEXAS syndrome
    Asami Kataoka
    Chisaki Mizumoto
    Junya Kanda
    Makoto Iwasaki
    Maki Sakurada
    Tomomi Oka
    Masakazu Fujimoto
    Yosuke Yamamoto
    Kohei Yamashita
    Yasuhito Nannya
    Seishi Ogawa
    Akifumi Takaori-Kondo
    International Journal of Hematology, 2023, 117 : 919 - 924
  • [7] Azacitidine is effective for the treatment of myelodysplastic syndrome and accompanied Sweet syndrome
    Lin, Che-Hung
    Yeh, Su-Peng
    Lin, Tze-Yi
    ANNALS OF HEMATOLOGY, 2015, 94 (11) : 1925 - 1926
  • [8] Azacitidine is effective for the treatment of myelodysplastic syndrome and accompanied Sweet syndrome
    Che-Hung Lin
    Su-Peng Yeh
    Tze-Yi Lin
    Annals of Hematology, 2015, 94 : 1925 - 1926
  • [9] Successful azacitidine based treatment of therapy related myelodysplastic syndrome with normal karyotype occurred after acute myeloid leukemia
    Saltarelli, F.
    Tatarelli, C.
    Spiriti, M. A. Aloe
    Naso, V.
    Bianchi, M. P.
    Bianchi, M. P.
    Conte, E.
    Proia, S.
    Ferrari, A.
    LEUKEMIA RESEARCH, 2013, 37 : S110 - S111
  • [10] Late Hematological Improvement of Myelodysplastic Syndrome Following Treatment with 5-Azacitidine Therapy
    Takaoka, Kensuke
    Hangaishi, Akira
    Ito, Ayumu
    Morioka, Takehiko
    Kida, Michiko
    Usuki, Kensuke
    INTERNAL MEDICINE, 2014, 53 (19) : 2241 - 2243
12345